- WeTrade Group Inc (NASDAQ: WETG) collaborated with MobiLab Medical Innovatives to launch a globally unparalleled and one-of-a-kind Monkeypox Virus testing kit with combined insurance coverage products with world-leading insurance companies.
- MobiLab is in the business of providing smart solutions for individuals and companies of all sizes self-screening tests covering a wide range of major diseases, infections, and viruses.
- Also Read: Rapid Test For Monkeypox? NY-Based Chembio Diagnostics Thinks They Can Pull It Off
- MobiLab agreed to conduct an in-depth introduction and coordination for WeTrade with several world-leading insurance companies in the U.S., Europe, and Asia and help kick off the designing and structuring of unprecedented insurance products primarily covering Monkeypox Virus patients.
- CEO Pijun Liu commented, “We expect the one-of-a-kind insurance coverage offered by Monkeypox testing kit products will bring us over US$100 million in revenue, given the considerable size of the potential market.”
- Related: WeTrade’s Monkeypox Test Kit Sales Top $50 Million As Shares Soar
- Price Action: WETG shares traded lower by 18.70% at $8.13 on the last check Tuesday.
Why Clearmind Medicine Stock Is Moving Higher
Clearmind Medicine shares are up Tuesday after the company announced it signed an exclusive patent licensing agreement with Yissum Research Development.
